BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9776707)

  • 1. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
    Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
    J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer.
    Okamoto K; Asahara H; Kobayashi T; Matsuno H; Hasunuma T; Kobata T; Sumida T; Nishioka K
    Gene Ther; 1998 Mar; 5(3):331-8. PubMed ID: 9614552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
    Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
    Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
    Weintraub JP; Eisenberg RA; Cohen PL
    J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
    Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.
    Kobata T; Takasaki K; Asahara H; Hong NM; Masuko-Hongo K; Kato T; Hirose S; Shirai T; Kayagaki N; Yagita H; Okumura K; Nishioka K
    Immunology; 1997 Oct; 92(2):206-13. PubMed ID: 9415028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras.
    MacDonald GC; Kakkanaiah VN; Sobel ES; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):444-9. PubMed ID: 7527820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.
    Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD
    Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hemizygous CD45 expression in the autoimmune Fasl(gld/gld) syndrome.
    Brooks WP; Lynes MA
    Cell Immunol; 2001 Aug; 212(1):24-34. PubMed ID: 11716526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.
    Mohamood AS; Trujillo CJ; Zheng D; Jie C; Murillo FM; Schneck JP; Hamad AR
    Int Immunol; 2006 Aug; 18(8):1265-77. PubMed ID: 16769751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
    Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
    J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in mature T cells by tumour necrosis factor.
    Zheng L; Fisher G; Miller RE; Peschon J; Lynch DH; Lenardo MJ
    Nature; 1995 Sep; 377(6547):348-51. PubMed ID: 7566090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
    Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo.
    Kosiewicz MM; Krishnan A; Worthington MT; Matriano JA; Ross WG
    Eur J Immunol; 2002 Jun; 32(6):1679-87. PubMed ID: 12115651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.